Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Notable: Empowered Relief for Severe Pain After Cesarean Delivery During the Inpatient Period Start date pushed from Oct 5, 2026 to Nov 30, 2026 Stanford UniversityNot applicable NCT07832240
  2. Minor: Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy · Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) Trial completed Merck Sharp & Dohme LLCPhase 3 NCT03425643
  3. Minor: GTAEXS617 · Advanced Solid Tumors Enrollment closed, study ongoing Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.Phase 1/2 NCT05985655
  4. Minor: AP306 at Fixed Doses in Dialysis · Hyperphosphatemia Enrollment closed, study ongoing R1 TherapeuticsPhase 2 NCT06712654
  5. Minor: AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, · Unresectable Locally Advanced or Metastatic Cancer Enrollment closed, study ongoing Aulos Bioscience, Inc.Phase 1/2 NCT05267626
  6. Minor: HLX43 in Combination With Serplulimab · Advanced Lung Cancer Enrollment closed, study ongoing Shanghai Henlius BiotechPhase 2 NCT07253142
  7. Minor: Rilzabrutinib · Graves' Disease Enrollment closed, study ongoing SanofiPhase 2 NCT06984627
  8. Minor: Impact of 18F-FES PET on the Therapeutic Treatment · Metastatic Breast Cancer Trial completed GE HealthcarePhase 4 NCT05486182
  9. Minor: Gingivitis and Plaque From a Marketed Toothpaste Trial completed Procter and GamblePhase 4 NCT07158112
  10. Minor: Investigational Tirzepatide (LY3298176) Doses · Type 2 Diabetes and Obesity Trial completed Eli Lilly and CompanyPhase 2 NCT06037252
  11. Minor: Ziftomenib · Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia Enrollment closed, study ongoing Kyowa Kirin Co., Ltd.Phase 2 NCT07623616
  12. Minor: SYNC-T Therapy SV-102 · Metastatic Castration-Resistant Prostate Cancer Enrollment closed, study ongoing Syncromune, Inc.Phase 2 NCT06533644
  13. Minor: Subcutaneous Trastuzumab Deruxtecan · Metastatic Solid Tumors Enrollment closed, study ongoing Daiichi SankyoPhase 1 NCT07015697
  14. Minor: Gingivitis and Systemic Biomarkers Trial completed Procter and GamblePhase 1 NCT06962956
  15. Minor: Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma Enrollment closed, study ongoing Shenzhen Fosun Kairos Biotechnology Co., Ltd.Early Phase 1 NCT07606937
  16. Minor: Nutritional Status · Chronic Kidney Disease Receiving 7.2% Amino Acids During Hemodialysis Trial completed PT Otsuka IndonesiaNot specified NCT07881627
  17. Minor: Analysis of Performance and Safety of MED-EL Cochlear Implants Trial status changed: Not Yet Recruiting → Active, Not Recruiting MED-EL Elektromedizinische Geräte GmbHNot specified NCT07777562
  18. Minor: Bladder EpiCheck European Haematuria Study Enrollment closed, study ongoing Nucleix Ltd.Not specified NCT06818136
  19. Minor: Combined Use of Cosmetic Products for Dry and Itchy Skin Completed without a posted recruiting period Lacer S.A.Not applicable NCT07695805
  20. Minor: Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose · Type 1 and Type 2 Diabetes Mellitus Enrollment closed, study ongoing Hoffmann-La RocheNot applicable NCT06704672
  21. Minor: Collagen-based Medical Device Treatment Combined With Physiotherapy · Achilles Tendinopathy Trial completed Guna S.p.aNot applicable NCT05464498
  22. Minor: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device Enrollment closed, study ongoing Microvention-Terumo, Inc.Not applicable NCT04839705
  23. Minor: Health Care Use and Costs · Early Stage Alzheimer's Disease (AD) Trial completed Eli Lilly and CompanyNot specified NCT02951598
  24. Minor: Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome Trial status changed: Unknown → Completed Zenchi, Inc.Not applicable NCT05875233
  25. Minor: Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT) Enrollment closed, study ongoing A.Menarini Asia-Pacific Holdings Pte LtdNot specified NCT06938516